, Volume 20, Issue 6, pp 963-965
Date: 04 Oct 2013

Does hybrid imaging have a role in cardiac risk evaluation of the pre-renal transplant patient?

This is an excerpt from the content

In 2010, approximately 17,000 adults with end-stage renal disease (ESRD) underwent kidney transplantation in the United States while approximately 76,000 patients were on the waiting list, a 6% increase from the previous year.1 Considering the limited organ availability and ever growing demand, patients being considered for renal transplantation undergo comprehensive cardiac assessment. Such risk assessment has been widely adopted as being helpful in determining transplant candidacy especially in patients most likely to survive the procedure (without a cardiac event) and make optimal use of their allograft. The risk of cardiovascular events in significantly high in the first months after kidney transplantation, with the highest rate of mortality in the peritransplantation period.2-4 Furthermore, coronary artery disease (CAD) remains the leading cause of death post-renal transplantation in the long term, with approximately one-third of all such deaths due to myocardial infarction (MI).2

See related article, doi:10.1007/s12350-013-9761-8.